TALPHERA INC (TLPH) Stock Price, Quote, News and Overview
NASDAQ:TLPH - Nasdaq - US00444T2096 - Common Stock - Currency: USD
TLPH Quote, Performance and Key Statistics
NASDAQ:TLPH (8/15/2025, 4:30:01 PM)
0.4253
0 (-1%)
The current stock price of TLPH is 0.4253 USD. In the past month the price increased by 2.49%. In the past year, price decreased by -52.95%.
TLPH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 43.42 | 664.58B | ||
| JNJ | JOHNSON & JOHNSON | 17.66 | 425.41B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.83 | 245.46B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 240.45B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.4 | 232.88B | ||
| MRK | MERCK & CO. INC. | 10.94 | 211.45B | ||
| PFE | PFIZER INC | 7.42 | 142.93B | ||
| SNY | SANOFI-ADR | 11.21 | 121.39B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.2 | 98.58B | ||
| GSK | GSK PLC-SPON ADR | 8.61 | 79.42B | ||
| ZTS | ZOETIS INC | 24.78 | 68.61B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50 | 47.37B |
Related stock screener links
About TLPH
Company Profile
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The company is headquartered in San Mateo, California and currently employs 13 full-time employees. The company went IPO on 2011-02-11. The Company’s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. The Company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat and is being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit. Niyad is used in adult patients undergoing continuous renal replacement therapy (CRRT). LTX-608 is its nafamostat formulation for direct IV infusion being explored as an investigational product for one or more indications, including antiviral treatment, or treatment of acute respiratory distress syndrome (ARDS) disseminated intravascular coagulation (DIC), or acute pancreatitis. The Company’s two ready-to-use pre-filled syringe (PFS) product candidates include Fedsyra and phenylephrine.
Company Info
TALPHERA INC
1850 Gateway Drive, Suite 175
San Mateo CALIFORNIA US
Employees: 13
Phone: 16502163500
TALPHERA INC / TLPH FAQ
What is the stock price of TALPHERA INC today?
The current stock price of TLPH is 0.4253 USD. The price decreased by -1% in the last trading session.
What is the ticker symbol for TALPHERA INC stock?
The exchange symbol of TALPHERA INC is TLPH and it is listed on the Nasdaq exchange.
On which exchange is TLPH stock listed?
TLPH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TALPHERA INC stock?
9 analysts have analysed TLPH and the average price target is 4.25 USD. This implies a price increase of 899.3% is expected in the next year compared to the current price of 0.4253. Check the TALPHERA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TALPHERA INC worth?
TALPHERA INC (TLPH) has a market capitalization of 8.72M USD. This makes TLPH a Nano Cap stock.
How many employees does TALPHERA INC have?
TALPHERA INC (TLPH) currently has 13 employees.
What are the support and resistance levels for TALPHERA INC (TLPH) stock?
TALPHERA INC (TLPH) has a resistance level at 0.44. Check the full technical report for a detailed analysis of TLPH support and resistance levels.
Should I buy TALPHERA INC (TLPH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TLPH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TLPH, evaluating the profitability, health, valuation and growth aspects
- TALPHERA INC (TLPH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TALPHERA INC (TLPH) Sales and EPS estimates to see what analysts future expectations are.
- TALPHERA INC (TLPH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TALPHERA INC (TLPH) Insider and Institutional Ownership to learn about the owners and their transactions.
- TALPHERA INC (TLPH) Stock Chart to make your own analysis
- TALPHERA INC (TLPH) Latest news and press-releases to stay up to date.
Does TALPHERA INC (TLPH) stock pay dividends?
TLPH does not pay a dividend.
When does TALPHERA INC (TLPH) report earnings?
TALPHERA INC (TLPH) will report earnings on 2025-08-18.
What is the Price/Earnings (PE) ratio of TALPHERA INC (TLPH)?
TALPHERA INC (TLPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).
What is the Short Interest ratio of TALPHERA INC (TLPH) stock?
The outstanding short interest for TALPHERA INC (TLPH) is 2.49% of its float. Check the ownership tab for more information on the TLPH short interest.
TLPH Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TLPH. When comparing the yearly performance of all stocks, TLPH is a bad performer in the overall market: 94.26% of all stocks are doing better.
TLPH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TLPH. The financial health of TLPH is average, but there are quite some concerns on its profitability.
TLPH Financial Highlights
Over the last trailing twelve months TLPH reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS increased by 37.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.65% | ||
| ROE | -207.95% | ||
| Debt/Equity | 0 |
TLPH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to TLPH. The Buy consensus is the average rating of analysts ratings from 9 analysts.